It is a pharma private limited company based in Karnal, Haryana, India, established in 2007.
2007 | Karnal, Haryana, India | ActiveZ X Drugs Private Limited, a active private limited company, was established on 04 October 2007 in Karnal, Haryana, India. Engaging in pharmaceutical retailers & distributors within the professional, scientific and technical sector, it holds CIN: U51397HR2007PTC037275. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.10 M and a paid-up capital of ₹1.05 M.
Formerly known as Zx Greens Private Limited, Z X Drugs Private Limited. It upholds a compliant status. Its leadership includes Rajev Gupta (Whole-Time Director), Rekha Gupta (Whole-Time Director). Past directors included Pernika Gupta, Rajev Gupta, Rekha Gupta. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 871 Sector 13, Karnal, Haryana, 132001.
U51397HR2007PTC037275
037275
04 October 2007
₹1.10 M
₹1.05 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Z X Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajev Gupta | Whole-Time Director | 02 Apr 2021 | Current |
| Rekha Gupta | Whole-Time Director | 16 Jan 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Apr 2021 | Past |
| Pramod Abcsdd | Additional Director | 21 Mar 2020 | Past |
| Pramod Abcsdd | Additional Director | 07 Sep 2020 | Past |
| Pramod Abcsdd | Director | 28 Apr 2010 | Past |
| Pramod Abcsdd | Director | 28 Apr 2010 | Past |
| Pramod Abcsdd | Director | 22 Aug 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Z X Drugs Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 19.12% decrease. The company also saw a substantial fall in profitability, with a 64.28% decrease in profit. The company's net worth moved up by a moderate rise of 0.42%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Z X Drugs had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Z X Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Z X Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Z X Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Z X Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Z X Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Rajev Gupta was appointed as a Whole-time director was appointed as a Whole-time director on 02 Apr 2021 & has been associated with this company since 4 years 7 months . was recorded as a recent event.
The activity Rekha Gupta was appointed as a Whole-time director was appointed as a Whole-time director on 16 Jan 2020 & has been associated with this company since 5 years 10 months . was completed.
Z X Drugs Private Limited was registered on 04 Oct 2007 with Roc Delhi & aged 18 years 1 month as per MCA records. was recorded as a recent event.
The CIN of Z X Drugs Private Limited is U51397HR2007PTC037275.
Z X Drugs Private Limited is headquartered at 871 Sector 13, Karnal, Haryana, 132001.
Z X Drugs Private Limited was incorporated on 04 October 2007.
The current directors of Z X Drugs Private Limited are
The primary industry of Z X Drugs Private Limited is Professional, Scientific And Technical.
Z X Drugs Private Limited is unlisted.
The authorized capital of Z X Drugs Private Limited is ₹1.10 M, and the paid-up capital is ₹1.05 M.
The compliance status of Z X Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX